Serlopitant
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Serlopitant, covering 2019-03-05 to 2021-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN) [Phase 2]